Constitutively active NF-κB has been detected in malignant cells derived from patients with multiple myeloma, acute myeloid leukemia, acute lymphocytic leukemia, and chronic myeloid leukemia [4,5]. This evidence concerns the gene NFKB1 and acute myeloid leukemia.